The genetic test maps 14 metabolic pathways across 49 peptides and 150+ insights, allowing PlexusDx to recommend whether you should start with oral semaglutide ($289/mo), compounded semaglutide injection ($189/mo), or tirzepatide-based options
The SOUL trial is being described as a landmark study for cardiovascular outcomes in high-risk diabetes patients
Attacks are agonizing, exhausting, and disruptive to the lives of these children
The intent behind its design was to influence fat metabolism without driving tissue growth or affecting insulin sensitivity the way full growth hormone can
The challenge for brands is to find ways to reignite food joy in a world of lower appetite and higher scrutiny
Employer-sponsored self-funded: 22% weight-loss coverage probability Employer-sponsored fully insured: 38% weight-loss coverage probability Individual marketplace: 45% weight-loss coverage probability Question 2: Does your Summary Plan Description list weight-loss medication exclusions